Exome and Tissue-Associated Microbiota as Predictive Markers of Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer

Autores
Takenaka, Isabella Kuniko T. M.; Bartelli, Thais F.; Defelicibus, Alexandre; Sendoya, Juan Martín; Golubicki, Mariano; Robbio, Juan; Serpa, Marianna S.; Branco, Gabriela P.; Santos, Luana B. C.; Claro, Laura C. L.; Oliveira dos Santos, Gabriel; Kupper, Bruna E. C.; da Silva, Israel T.; Llera, Andrea Sabina; de Mello, Celso A. L.; Riechelmann, Rachel P.; Dias Neto, Emmanuel; Iseas, Soledad; Aguiar, Samuel; Nunes, Diana Noronha
Año de publicación
2022
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
The clinical and pathological responses to multimodal neoadjuvant therapy in locally advanced rectal cancers (LARCs) remain unpredictable, and robust biomarkers are still lacking. Recent studies have shown that tumors present somatic molecular alterations related to better treatment response, and it is also clear that tumor-associated bacteria are modulators of chemotherapy and immunotherapy efficacy, therefore having implications for long-term survivorship and a good potential as the biomarkers of outcome. Here, we performed whole exome sequencing and 16S ribosomal RNA (rRNA) amplicon sequencing from 44 pre-treatment LARC biopsies from Argentinian and Brazilian patients, treated with neoadjuvant chemoradiotherapy or total neoadjuvant treatment, searching for predictive biomarkers of response (responders, n = 17; non-responders, n = 27). In general, the somatic landscape of LARC was not capable to predict a response; however, a significant enrichment in mutational signature SBS5 was observed in non-responders (p = 0.0021), as well as the co-occurrence of APC and FAT4 mutations (p < 0.05). Microbiota studies revealed a similar alpha and beta diversity of bacteria between response groups. Yet, the linear discriminant analysis (LDA) of effect size indicated an enrichment of Hungatella, Flavonifractor, and Methanosphaera (LDA score ≥3) in the pre-treatment biopsies of responders, while non-responders had a higher abundance of Enhydrobacter, Paraprevotella (LDA score ≥3) and Finegoldia (LDA score ≥4). Altogether, the evaluation of these biomarkers in pre-treatment biopsies could eventually predict a neoadjuvant treatment response, while in post-treatment samples, it could help in guiding non-operative treatment strategies.
Fil: Takenaka, Isabella Kuniko T. M.. No especifíca;
Fil: Bartelli, Thais F.. No especifíca;
Fil: Defelicibus, Alexandre. No especifíca;
Fil: Sendoya, Juan Martín. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigaciones Bioquímicas de Buenos Aires. Fundación Instituto Leloir. Instituto de Investigaciones Bioquímicas de Buenos Aires; Argentina
Fil: Golubicki, Mariano. Gobierno de la Ciudad de Buenos Aires. Hospital de Gastroenterología "Dr. Carlos B. Udaondo"; Argentina
Fil: Robbio, Juan. No especifíca;
Fil: Serpa, Marianna S.. No especifíca;
Fil: Branco, Gabriela P.. No especifíca;
Fil: Santos, Luana B. C.. No especifíca;
Fil: Claro, Laura C. L.. No especifíca;
Fil: Oliveira dos Santos, Gabriel. No especifíca;
Fil: Kupper, Bruna E. C.. No especifíca;
Fil: da Silva, Israel T.. No especifíca;
Fil: Llera, Andrea Sabina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigaciones Bioquímicas de Buenos Aires. Fundación Instituto Leloir. Instituto de Investigaciones Bioquímicas de Buenos Aires; Argentina
Fil: de Mello, Celso A. L.. No especifíca;
Fil: Riechelmann, Rachel P.. No especifíca;
Fil: Dias Neto, Emmanuel. Universidade de Sao Paulo; Brasil
Fil: Iseas, Soledad. Gobierno de la Ciudad de Buenos Aires. Hospital de Gastroenterología "Dr. Carlos B. Udaondo"; Argentina
Fil: Aguiar, Samuel. No especifíca;
Fil: Nunes, Diana Noronha. No especifíca;
Materia
BIOMARKERS OF TREATMENT RESPONSE
LOCALLY ADVANCED RECTAL CANCER
MICROBIOTA
MUTATIONAL SIGNATURES
NEOADJUVANT CHEMORADIOTHERAPY
WHOLE EXOME SEQUENCING
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/214903

id CONICETDig_3127f8b9e9c7ac714249387a463135b7
oai_identifier_str oai:ri.conicet.gov.ar:11336/214903
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Exome and Tissue-Associated Microbiota as Predictive Markers of Response to Neoadjuvant Treatment in Locally Advanced Rectal CancerTakenaka, Isabella Kuniko T. M.Bartelli, Thais F.Defelicibus, AlexandreSendoya, Juan MartínGolubicki, MarianoRobbio, JuanSerpa, Marianna S.Branco, Gabriela P.Santos, Luana B. C.Claro, Laura C. L.Oliveira dos Santos, GabrielKupper, Bruna E. C.da Silva, Israel T.Llera, Andrea Sabinade Mello, Celso A. L.Riechelmann, Rachel P.Dias Neto, EmmanuelIseas, SoledadAguiar, SamuelNunes, Diana NoronhaBIOMARKERS OF TREATMENT RESPONSELOCALLY ADVANCED RECTAL CANCERMICROBIOTAMUTATIONAL SIGNATURESNEOADJUVANT CHEMORADIOTHERAPYWHOLE EXOME SEQUENCINGhttps://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3The clinical and pathological responses to multimodal neoadjuvant therapy in locally advanced rectal cancers (LARCs) remain unpredictable, and robust biomarkers are still lacking. Recent studies have shown that tumors present somatic molecular alterations related to better treatment response, and it is also clear that tumor-associated bacteria are modulators of chemotherapy and immunotherapy efficacy, therefore having implications for long-term survivorship and a good potential as the biomarkers of outcome. Here, we performed whole exome sequencing and 16S ribosomal RNA (rRNA) amplicon sequencing from 44 pre-treatment LARC biopsies from Argentinian and Brazilian patients, treated with neoadjuvant chemoradiotherapy or total neoadjuvant treatment, searching for predictive biomarkers of response (responders, n = 17; non-responders, n = 27). In general, the somatic landscape of LARC was not capable to predict a response; however, a significant enrichment in mutational signature SBS5 was observed in non-responders (p = 0.0021), as well as the co-occurrence of APC and FAT4 mutations (p < 0.05). Microbiota studies revealed a similar alpha and beta diversity of bacteria between response groups. Yet, the linear discriminant analysis (LDA) of effect size indicated an enrichment of Hungatella, Flavonifractor, and Methanosphaera (LDA score ≥3) in the pre-treatment biopsies of responders, while non-responders had a higher abundance of Enhydrobacter, Paraprevotella (LDA score ≥3) and Finegoldia (LDA score ≥4). Altogether, the evaluation of these biomarkers in pre-treatment biopsies could eventually predict a neoadjuvant treatment response, while in post-treatment samples, it could help in guiding non-operative treatment strategies.Fil: Takenaka, Isabella Kuniko T. M.. No especifíca;Fil: Bartelli, Thais F.. No especifíca;Fil: Defelicibus, Alexandre. No especifíca;Fil: Sendoya, Juan Martín. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigaciones Bioquímicas de Buenos Aires. Fundación Instituto Leloir. Instituto de Investigaciones Bioquímicas de Buenos Aires; ArgentinaFil: Golubicki, Mariano. Gobierno de la Ciudad de Buenos Aires. Hospital de Gastroenterología "Dr. Carlos B. Udaondo"; ArgentinaFil: Robbio, Juan. No especifíca;Fil: Serpa, Marianna S.. No especifíca;Fil: Branco, Gabriela P.. No especifíca;Fil: Santos, Luana B. C.. No especifíca;Fil: Claro, Laura C. L.. No especifíca;Fil: Oliveira dos Santos, Gabriel. No especifíca;Fil: Kupper, Bruna E. C.. No especifíca;Fil: da Silva, Israel T.. No especifíca;Fil: Llera, Andrea Sabina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigaciones Bioquímicas de Buenos Aires. Fundación Instituto Leloir. Instituto de Investigaciones Bioquímicas de Buenos Aires; ArgentinaFil: de Mello, Celso A. L.. No especifíca;Fil: Riechelmann, Rachel P.. No especifíca;Fil: Dias Neto, Emmanuel. Universidade de Sao Paulo; BrasilFil: Iseas, Soledad. Gobierno de la Ciudad de Buenos Aires. Hospital de Gastroenterología "Dr. Carlos B. Udaondo"; ArgentinaFil: Aguiar, Samuel. No especifíca;Fil: Nunes, Diana Noronha. No especifíca;Frontiers Media2022-03info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/214903Takenaka, Isabella Kuniko T. M.; Bartelli, Thais F.; Defelicibus, Alexandre; Sendoya, Juan Martín; Golubicki, Mariano; et al.; Exome and Tissue-Associated Microbiota as Predictive Markers of Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer; Frontiers Media; Frontiers in Oncology; 12; 3-2022; 1-162234-943XCONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.3389/fonc.2022.809441info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:58:18Zoai:ri.conicet.gov.ar:11336/214903instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:58:19.178CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Exome and Tissue-Associated Microbiota as Predictive Markers of Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer
title Exome and Tissue-Associated Microbiota as Predictive Markers of Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer
spellingShingle Exome and Tissue-Associated Microbiota as Predictive Markers of Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer
Takenaka, Isabella Kuniko T. M.
BIOMARKERS OF TREATMENT RESPONSE
LOCALLY ADVANCED RECTAL CANCER
MICROBIOTA
MUTATIONAL SIGNATURES
NEOADJUVANT CHEMORADIOTHERAPY
WHOLE EXOME SEQUENCING
title_short Exome and Tissue-Associated Microbiota as Predictive Markers of Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer
title_full Exome and Tissue-Associated Microbiota as Predictive Markers of Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer
title_fullStr Exome and Tissue-Associated Microbiota as Predictive Markers of Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer
title_full_unstemmed Exome and Tissue-Associated Microbiota as Predictive Markers of Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer
title_sort Exome and Tissue-Associated Microbiota as Predictive Markers of Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer
dc.creator.none.fl_str_mv Takenaka, Isabella Kuniko T. M.
Bartelli, Thais F.
Defelicibus, Alexandre
Sendoya, Juan Martín
Golubicki, Mariano
Robbio, Juan
Serpa, Marianna S.
Branco, Gabriela P.
Santos, Luana B. C.
Claro, Laura C. L.
Oliveira dos Santos, Gabriel
Kupper, Bruna E. C.
da Silva, Israel T.
Llera, Andrea Sabina
de Mello, Celso A. L.
Riechelmann, Rachel P.
Dias Neto, Emmanuel
Iseas, Soledad
Aguiar, Samuel
Nunes, Diana Noronha
author Takenaka, Isabella Kuniko T. M.
author_facet Takenaka, Isabella Kuniko T. M.
Bartelli, Thais F.
Defelicibus, Alexandre
Sendoya, Juan Martín
Golubicki, Mariano
Robbio, Juan
Serpa, Marianna S.
Branco, Gabriela P.
Santos, Luana B. C.
Claro, Laura C. L.
Oliveira dos Santos, Gabriel
Kupper, Bruna E. C.
da Silva, Israel T.
Llera, Andrea Sabina
de Mello, Celso A. L.
Riechelmann, Rachel P.
Dias Neto, Emmanuel
Iseas, Soledad
Aguiar, Samuel
Nunes, Diana Noronha
author_role author
author2 Bartelli, Thais F.
Defelicibus, Alexandre
Sendoya, Juan Martín
Golubicki, Mariano
Robbio, Juan
Serpa, Marianna S.
Branco, Gabriela P.
Santos, Luana B. C.
Claro, Laura C. L.
Oliveira dos Santos, Gabriel
Kupper, Bruna E. C.
da Silva, Israel T.
Llera, Andrea Sabina
de Mello, Celso A. L.
Riechelmann, Rachel P.
Dias Neto, Emmanuel
Iseas, Soledad
Aguiar, Samuel
Nunes, Diana Noronha
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv BIOMARKERS OF TREATMENT RESPONSE
LOCALLY ADVANCED RECTAL CANCER
MICROBIOTA
MUTATIONAL SIGNATURES
NEOADJUVANT CHEMORADIOTHERAPY
WHOLE EXOME SEQUENCING
topic BIOMARKERS OF TREATMENT RESPONSE
LOCALLY ADVANCED RECTAL CANCER
MICROBIOTA
MUTATIONAL SIGNATURES
NEOADJUVANT CHEMORADIOTHERAPY
WHOLE EXOME SEQUENCING
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.2
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv The clinical and pathological responses to multimodal neoadjuvant therapy in locally advanced rectal cancers (LARCs) remain unpredictable, and robust biomarkers are still lacking. Recent studies have shown that tumors present somatic molecular alterations related to better treatment response, and it is also clear that tumor-associated bacteria are modulators of chemotherapy and immunotherapy efficacy, therefore having implications for long-term survivorship and a good potential as the biomarkers of outcome. Here, we performed whole exome sequencing and 16S ribosomal RNA (rRNA) amplicon sequencing from 44 pre-treatment LARC biopsies from Argentinian and Brazilian patients, treated with neoadjuvant chemoradiotherapy or total neoadjuvant treatment, searching for predictive biomarkers of response (responders, n = 17; non-responders, n = 27). In general, the somatic landscape of LARC was not capable to predict a response; however, a significant enrichment in mutational signature SBS5 was observed in non-responders (p = 0.0021), as well as the co-occurrence of APC and FAT4 mutations (p < 0.05). Microbiota studies revealed a similar alpha and beta diversity of bacteria between response groups. Yet, the linear discriminant analysis (LDA) of effect size indicated an enrichment of Hungatella, Flavonifractor, and Methanosphaera (LDA score ≥3) in the pre-treatment biopsies of responders, while non-responders had a higher abundance of Enhydrobacter, Paraprevotella (LDA score ≥3) and Finegoldia (LDA score ≥4). Altogether, the evaluation of these biomarkers in pre-treatment biopsies could eventually predict a neoadjuvant treatment response, while in post-treatment samples, it could help in guiding non-operative treatment strategies.
Fil: Takenaka, Isabella Kuniko T. M.. No especifíca;
Fil: Bartelli, Thais F.. No especifíca;
Fil: Defelicibus, Alexandre. No especifíca;
Fil: Sendoya, Juan Martín. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigaciones Bioquímicas de Buenos Aires. Fundación Instituto Leloir. Instituto de Investigaciones Bioquímicas de Buenos Aires; Argentina
Fil: Golubicki, Mariano. Gobierno de la Ciudad de Buenos Aires. Hospital de Gastroenterología "Dr. Carlos B. Udaondo"; Argentina
Fil: Robbio, Juan. No especifíca;
Fil: Serpa, Marianna S.. No especifíca;
Fil: Branco, Gabriela P.. No especifíca;
Fil: Santos, Luana B. C.. No especifíca;
Fil: Claro, Laura C. L.. No especifíca;
Fil: Oliveira dos Santos, Gabriel. No especifíca;
Fil: Kupper, Bruna E. C.. No especifíca;
Fil: da Silva, Israel T.. No especifíca;
Fil: Llera, Andrea Sabina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigaciones Bioquímicas de Buenos Aires. Fundación Instituto Leloir. Instituto de Investigaciones Bioquímicas de Buenos Aires; Argentina
Fil: de Mello, Celso A. L.. No especifíca;
Fil: Riechelmann, Rachel P.. No especifíca;
Fil: Dias Neto, Emmanuel. Universidade de Sao Paulo; Brasil
Fil: Iseas, Soledad. Gobierno de la Ciudad de Buenos Aires. Hospital de Gastroenterología "Dr. Carlos B. Udaondo"; Argentina
Fil: Aguiar, Samuel. No especifíca;
Fil: Nunes, Diana Noronha. No especifíca;
description The clinical and pathological responses to multimodal neoadjuvant therapy in locally advanced rectal cancers (LARCs) remain unpredictable, and robust biomarkers are still lacking. Recent studies have shown that tumors present somatic molecular alterations related to better treatment response, and it is also clear that tumor-associated bacteria are modulators of chemotherapy and immunotherapy efficacy, therefore having implications for long-term survivorship and a good potential as the biomarkers of outcome. Here, we performed whole exome sequencing and 16S ribosomal RNA (rRNA) amplicon sequencing from 44 pre-treatment LARC biopsies from Argentinian and Brazilian patients, treated with neoadjuvant chemoradiotherapy or total neoadjuvant treatment, searching for predictive biomarkers of response (responders, n = 17; non-responders, n = 27). In general, the somatic landscape of LARC was not capable to predict a response; however, a significant enrichment in mutational signature SBS5 was observed in non-responders (p = 0.0021), as well as the co-occurrence of APC and FAT4 mutations (p < 0.05). Microbiota studies revealed a similar alpha and beta diversity of bacteria between response groups. Yet, the linear discriminant analysis (LDA) of effect size indicated an enrichment of Hungatella, Flavonifractor, and Methanosphaera (LDA score ≥3) in the pre-treatment biopsies of responders, while non-responders had a higher abundance of Enhydrobacter, Paraprevotella (LDA score ≥3) and Finegoldia (LDA score ≥4). Altogether, the evaluation of these biomarkers in pre-treatment biopsies could eventually predict a neoadjuvant treatment response, while in post-treatment samples, it could help in guiding non-operative treatment strategies.
publishDate 2022
dc.date.none.fl_str_mv 2022-03
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/214903
Takenaka, Isabella Kuniko T. M.; Bartelli, Thais F.; Defelicibus, Alexandre; Sendoya, Juan Martín; Golubicki, Mariano; et al.; Exome and Tissue-Associated Microbiota as Predictive Markers of Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer; Frontiers Media; Frontiers in Oncology; 12; 3-2022; 1-16
2234-943X
CONICET Digital
CONICET
url http://hdl.handle.net/11336/214903
identifier_str_mv Takenaka, Isabella Kuniko T. M.; Bartelli, Thais F.; Defelicibus, Alexandre; Sendoya, Juan Martín; Golubicki, Mariano; et al.; Exome and Tissue-Associated Microbiota as Predictive Markers of Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer; Frontiers Media; Frontiers in Oncology; 12; 3-2022; 1-16
2234-943X
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/doi/10.3389/fonc.2022.809441
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Frontiers Media
publisher.none.fl_str_mv Frontiers Media
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1842269514883923968
score 13.13397